Clinical Trial Update: Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer. [Phase 2]

View source ↗

Summary

Investigator-initiated Phase 2 pilot study evaluating CYTALUX (pafolacianine) for intraoperative detection of malignant tissue during cancer surgery; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastrointestinal Cancer
• Gynecologic Cancer

Drugs mentioned

• Cytalux (pafolacianine)

Snippet

Sponsor: John Waters | Conditions: Esophageal Cancer, Gastrointestinal Cancers | Phase 2 | Status: RECRUITING